Clinical Trials · NCT07429032

The Effect of AMG 133 on Gastric Emptying

Phase
Phase 1
Recruitment status
Completed
Sponsor
Amgen
Enrollment
57
Start date
Apr 2025
Locations
1 site, United States
Primary endpoint
Maximum Observed Plasma Concentration (Cmax) for Acetaminophen
View Maridebart-Cafraglutide compound reference